A Validated Prognostic Biomarker Score for Adult Patients with Nonmetastatic Soft Tissue Sarcomas of the Trunk and Extremities
BACKGROUND: The prognostic value of serum biomarkers in soft tissue sarcoma (STS) is limited, and its clinical applicability is compromised by a common inability to adjust for important confounders. The aim of this study was to determine the prognostic value of pretreatment biomarkers on disease-spe...
Main Authors: | Katja Maretty-Kongstad, Ninna Aggerholm-Pedersen, Johnny Keller, Akmal Safwat |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-12-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523317303017 |
Similar Items
-
The Prognostic Value of Serum Biomarkers in Localized Bone Sarcoma
by: Ninna Aggerholm-Pedersen, et al.
Published: (2016-08-01) -
Comorbidity in Adult Bone Sarcoma Patients: A Population-Based Cohort Study
by: Ninna Aggerholm-Pedersen, et al.
Published: (2014-01-01) -
Population-based Aarhus Sarcoma Registry: validity, completeness of registration, and incidence of bone and soft tissue sarcomas in western Denmark
by: Maretty-Nielsen K, et al.
Published: (2013-03-01) -
Pazopanib in the Treatment of Bone Sarcomas: Clinical Experience
by: Ninna Aggerholm-Pedersen, et al.
Published: (2020-02-01) -
Use of Healthcare Services Two Years before Diagnosis in Danish Sarcoma Patients, 2000–2013
by: Mathias Rædkjær, et al.
Published: (2019-01-01)